You have 9 free searches left this month | for more free features.

bms-986205

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Cancer Trial in Hangzhou (BMS-986205, Nivolumab)

Completed
  • Advanced Cancer
  • BMS-986205
  • Nivolumab
  • Hangzhou, Zhejiang, China
    Local Institution
Feb 3, 2022

Advanced Cancer Trial in Worldwide (Relatlimab, Nivolumab, BMS-986205)

Recruiting
  • Advanced Cancer
  • Relatlimab
  • +3 more
  • Duarte, California
  • +23 more
Oct 24, 2022

Advanced Cancer, Melanoma, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • +2 more
  • BMS-986205
  • +2 more
  • Tucson, Arizona
  • +46 more
Aug 18, 2022

Urinary Bladder Tumors Trial in Worldwide (Nivolumab, BCG, BMS-986205)

Completed
  • Urinary Bladder Neoplasms
  • Nivolumab
  • +2 more
  • Los Angeles, California
  • +88 more
Jan 24, 2023

Melanoma, Skin Cancer Trial in Worldwide (BMS-986205, Nivolumab, Placebo)

Completed
  • Melanoma
  • Skin Cancer
  • BMS-986205
  • +2 more
  • Los Angeles, California
  • +62 more
Jun 18, 2021

Advanced Gastric Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Relatlimab)

Active, not recruiting
  • Advanced Gastric Cancer
  • Nivolumab
  • +4 more
  • Phoenix, Arizona
  • +34 more
Aug 18, 2022

Melanoma Stage III, Melanoma Stage IV Trial in Boston (Nivolumab, BMS-986205, Ipilimumab)

Withdrawn
  • Melanoma Stage III
  • Melanoma Stage IV
  • Boston, Massachusetts
  • +1 more
Feb 3, 2020

Healthy Trial in Austin (BMS-986205, omeprazole)

Completed
  • Healthy
  • Austin, Texas
    PPD Phase I Clinic
Sep 19, 2019

Advanced Cancer Trial in Chuo-ku (BMS-986205, Nivolumab)

Completed
  • Advanced Cancer
  • BMS-986205
  • Nivolumab
  • Chuo-ku, Tokyo, Japan
    Local Institution
Mar 29, 2019

Advanced Cancer Trial in Worldwide (Nivolumab, Dasatinib, Relatlimab)

Terminated
  • Advanced Cancer
  • Nivolumab
  • +4 more
  • Duarte, California
  • +49 more
Feb 23, 2021

Head Neck Cancer Trial in Pittsburgh (Nivolumab, BMS-986205, Cetuximab)

Withdrawn
  • Head and Neck Cancer
  • Nivolumab
  • +5 more
  • Pittsburgh, Pennsylvania
    Allegheny General Hospital
Apr 16, 2019

Healthy Participants Trial in Nottingham (BMS-986205)

Completed
  • Healthy Participants
  • BMS-986205
  • Nottingham, Ruddington Fields, United Kingdom
    Quotient Clinical
Jun 26, 2018

Malignancies Multiple Trial in Austin (BMS-986205, Itraconazole, Rifampin)

Completed
  • Malignancies Multiple
  • BMS-986205
  • +2 more
  • Austin, Texas
    PPD
Feb 26, 2018

Healthy Volunteers Trial in Austin (BMS-986205)

Completed
  • Healthy Volunteers
  • BMS-986205
  • Austin, Texas
    PPD Austin Clinic
Feb 22, 2018

Healthy Volunteers Trial in Austin (BMS-986205)

Completed
  • Healthy Volunteers
  • BMS-986205
  • Austin, Texas
    PPD Austin Clinic
Jan 17, 2018

Cancer Trial in Madison (BMS-986205)

Completed
  • Cancer
  • BMS-986205
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc.
Oct 31, 2017

Lung Cancer, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Chemotherapy)

Withdrawn
  • Lung Cancer
  • Non-Small Cell Lung Cancer
  • BMS-986205
  • +2 more
  • San Diego, California
  • +82 more
Apr 26, 2018